SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending amid speculation around potential U.S. government investment in its Greenland rare earth project, driving significant price movement and high trading volume. Community discussions revolve around the validity of news reports, potential short squeezes, and the long-term prospects of the company given the increasing demand for rare earth minerals. Some traders believe this could reach new highs, while others are wary of potential volatility after initial reports of government interest faced pushback.

Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Spruce Biosciences Inc

SPRB is experiencing a surge in activity, with the community highlighting a significant gap up and multiple trading halts. Discussions revolve around the potential for further gains, comparisons to other high-flying stocks, and speculation about the reasons behind the sudden price movement, including potential connections to Wu Tang clan. Some traders caution about the risks associated with the volatility and the possibility of a correction.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending following news of a major deal with OpenAI, including a significant processor purchase and potential equity stake, sending the stock soaring. Community discussions revolve around the deal's implications for AMD's competition with Nvidia and the broader AI chip market. Some are skeptical, questioning the financial dynamics of the agreement, while others see it as a validation of AMD's technology and growth potential.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending amid speculation about a potential partnership with Tesla, fueled by a teaser video and upcoming announcements. Community discussions revolve around the possibility of autonomous flight integration and the potential impact on the eVTOL market, with some traders expressing high bullish sentiment and anticipating a significant breakout. The stock's recent price surge and high trading volume indicate increased investor interest in Archer's future prospects within the electric vertical takeoff and landing (eVTOL) industry.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is currently trending with community members actively discussing potential breakouts and key resistance levels, as well as corporate accumulation. There is excitement around new projects launching on the Solana blockchain and bullish sentiment fueled by talk of possible ETF approvals and the potential impact on institutional investment. The community also mentions other tokens within the Solana ecosystem.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending due to ongoing discussions around quantum computing's potential and its role in energy efficiency, particularly within data centers. Community members are debating the stock's valuation, comparing it to peers like IONQ and RGTI, while also weighing its long-term potential against short-term risks and potential pullbacks. Some traders are taking profits, while others remain bullish, citing positive technical analysis and potential catalysts like government contracts.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma ($FIG) is trending amid discussions about its availability within ChatGPT apps and a recent spike in price, with some speculating about potential integration announcements. The community is actively debating the reasons behind the move, including potential short squeezes and the impact of a recent DEVDAY. Some investors are optimistic about the company's long-term potential, while others express concerns about lockup periods and potential trapping of retail investors.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as community members express bullish sentiment and highlight its strong, active community. Talk centers around the token's potential, particularly within the Solana ecosystem and the Pump.fun platform. The community emphasizes long-term conviction and organic growth.

Pump.fun

Pump.fun ($PUMP) is trending as traders discuss its potential for significant gains, especially within the Solana ($SOL) meme coin ecosystem. Community members are focused on the "We're All Gonna Make It" ($WAGMI) narrative and touting the strength and positivity of the $WAGMI community, with some anticipating major CEX listings soon. Others highlight the platform's buyback program and creator rewards, while some traders express concerns about excessive shilling.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is trending due to a mix of bullish sentiment and skepticism surrounding its valuation within the quantum computing sector; the community is actively debating whether the stock's impressive gains are justified, with some highlighting potential overvaluation and an imminent offering, while others emphasize the company's technology and future potential. Discussions also include comparisons to other quantum computing stocks and established tech companies, as well as observations on short selling activity.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CLPT Expands Into Robotic System Supporting Cell and Gene Therapies

ClearPoint's new Robotic Neuro-Navigation System merges proven software with KUKA robotics to boost precision in cell and gene therapy delivery.

GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent

GE HealthCare strengthens its radiopharmaceutical portfolio by licensing Lantheus' PSMA PET imaging agent, PYLARIFY, for commercialization in Japan.

Masimo Completes Divestment of Consumer Audio Business to HARMAN

MASI completes sale of Sound United to HARMAN, sharpening focus on core healthcare, boosting margins, and funding buybacks.

Here's Why You Should Add Inogen Stock to Your Portfolio Now

Expanding product portfolio and high prospects for POC raise optimism for INGN stock.

Are Medical Stocks Lagging  AxoGen (AXGN) This Year?

Here is how AxoGen (AXGN) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.

Does AxoGen (AXGN) Have the Potential to Rally 53.1% as Wall Street Analysts Expect?

The mean of analysts' price targets for AxoGen (AXGN) points to a 53.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Axogen, Inc. (AXGN) announced on Monday that the U.S. Food and Drug Administration (FDA) has postponed the date by which it would decide on the company’s application requesting approval for Avance Nerve Graft.Shares of the company tumbled 15% in Monday’s pre-market session after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.axogeninc.com/press-releases/detail/1007/axogen-provides-update-on-fda-review-timeline-for-avance">announced</a> that the agency pushed the date of the decision by three months to Dec. 5, 2025. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves.An "off-the-shelf" processed human nerve allograft is a biologically active implant made from donated human nerve tissue that is surgically treated to remove cellular and non-cellular debris, preserving the native nerve's structural integrity. Unlike traditional autografts, allografts are "off-the-shelf," meaning they are immediately available for surgical use.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/AXGN">AXGN stock</a> fell from ‘neutral’ to ‘bearish’ territory over the past 24 hours while message volume remained at ‘low’ levels.The company said that it received communication from the FDA on August 22, indicating that the information it submitted in response to an FDA information request was deemed a major amendment to its initial application filed in September 2024 and accepted by the agency in November. The company submitted fresh data, including substantial new manufacturing and facility data, in response to the request.FDA subsequently extended the date for making its decision, allowing for additional time to review the submission. The FDA also told the company that it now expects to provide feedback on product labelling in November.CEO Michael Dale said that the company looks forward to continuing engagement with the FDA to get Avance approved.AXGN stock is down by 1% this year but up by about 28% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-slides-to-july-levels-ethereum-retreats-from-weekend-highs/chssNkNRd1i">Bitcoin Slides To July Levels, Ethereum Retreats From Weekend Highs – $840M Liquidated In Crypto Selloff</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Why Is Axogen Stock Down 15% In Pre-Market Today?

Axogen stock tumbled after the company announced that the U.S. FDA pushed the date of the decision regarding approval for Avance Nerve Graft by three months.

Equity

The stock tumbled after the company announced that the U.S. FDA pushed the date of the decision regarding approval for Avance Nerve Graft by three months.


Wall Street Analysts Predict a 76.37% Upside in AxoGen (AXGN): Here's  What You Should Know

The average of price targets set by Wall Street analysts indicates a potential upside of 76.4% in AxoGen (AXGN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates

AxoGen (AXGN) delivered earnings and revenue surprises of +100.00% and +7.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Waters (WAT) Surpasses Q2 Earnings and Revenue Estimates

Waters (WAT) delivered earnings and revenue surprises of +0.68% and +3.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm’s products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.

Axogen Inc.

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$17.46
Prev Close	$17.88
Open	$18.00
Dividend Yield	0.00%
50-Day Moving Average	$15.63
Beta	1.13
Avg. Volume	877,366.19
PE Ratio	-169.16

52-Week High	$21.00
52-Week Low	$9.22
Market Capitalization	$822.71M
EPS (Annual)	-$0.2251
Price to Book	7.29
Revenue Per Employee	$414,464.60
Enterprise Value/EBITDA	N/A

AXGN
Axogen Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AXGN News

AXGN Axogen Inc.